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Abstract
Individuals in modern Western societies are experiencing increasing sedentary lifestyles,
overindulgence of high fat, high-sugar diets, and extremely sterilized conditions, putting
immense pressure on researchers and clinicians alike to come up with viable treatments for
conditions implicated with an aging society. Emerging research have published the benefits of
IMS and metabolic switching in a variety of neuroprotective, cellular stress resistance, and
neuroplasticity pathways in animal models and clinical results from randomized trials of IMS
regimens with susceptible human populations are soon to be published. The application of
genome editing and next-generation sequencing (NGS) strategies to clinical and
neurodegenerative research continues to elucidate the relationship between a patient’s specific
genetic background and modern environmental stressors towards disease pathology. This study
attempts to utilize novel CRISPR/Cas9 strategies to introduce targeted gene edits and explores the
role of reduced ketone-body synthesis/metabolism with 3-hydroxymethyl-3-methylglutaryl-CoA
lyase HMGCL KO, in the therapeutic and neuroprotective potential of intermittent metabolic
switching in 3xTg mice, genetically predisposed for Alzheimer pathology. IMS-mediated
attenuation of hippocampal spatial memory deficits was confirmed in 5-month-old 3xTg mice
using Morris Water Maze and Aβ1-40, Aβ1-42, total tau and p-tau levels were calculated
accordingly. Mice receiving time-restricted feeding (TRF) and caloric restriction (CR) regardless
of KO performed better in the hippocampal-dependent spatial memory test and ELISA analysis of
CSF revealed reduced p-tau levels of 3xTg WT TRF + CR mice relative to WT control or the two
experimental groups. Overall, genetic modifications of key metabolic enzymes highlight the
variable therapeutic results of the glucose to ketone metabolic switch on cognitive deficits
depending on an organism’s genetic background.
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Emergence of Alzheimer Disease
The NIH has stated that the percentage of the world population over 65 years old is expected to
double to 1.6 billion people by the year 2050, putting immense pressure on researchers and
society alike to provide reproducible solutions to the issues faced by an aging population and
their families (Hebert et al., 2013). Accordingly, the rising prevalence of Alzheimer disease
(AD) and other dementia-like disorders has placed genetic data analysis and transgenic animal
studies at the forefront of pharmacogenetics and clinical research. Progress in understanding
the complex etiology of early and late on-set forms of AD have largely stemmed from the
application of molecular and cellular manipulations against genetic backgrounds implicated in
disease progression and have shed light on the complex interaction of genetic and
environmental factors in the pathogenesis of AD. This proposal attempts to address three main
hypotheses: Can CRISPR/Cas9 transfected embryonic stem cells and surrogate transplantation
lead to viable chimeric HMGCL KO strain in 3xTg AD mice? How does IMS affect cognitive
abilities in 6-month-old 3xTg/HMGCL-/- compared to 3xTg/WT littermates? What effect does
IMS and gene KO have on levels of Aβ protein and p-tau concentrations? Is cell death observed
in hippocampal slices?
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Alzheimer Disease Pathology
Traditionally, Alzheimer disease pathology has been well characterized by the amyloid cascade
hypothesis (Hardy & Higgins, 1992). This study concludes that the extracellular aggregation of
amyloid beta (Aβ) protein from aberrant cleavage of the amyloid precursor protein (APP) leads
to neurotoxic amyloid plaques, ultimately contributing to the formation of intracellular
neurofibrillary tangles (NFTs), hyper-phosphorylated microtubule associated protein tau
pathology, and subsequent cell death (Hardy & Higgins, 1992, Grundke-Iqbal et al., 1986). Since
the early identification of mutations associated with APP, researchers have refined the diagnoses
of familial early onset forms of AD to also include mutations in presenilin-1 or presenilin-2, which
are the catalytic subunits of gamma-secretase, implicated in the pathway that generates the
insoluble Aβ1-42 protein aggregates (Lanoiselée et al., 2017, Murphy & LeVine, 2010).
Recently, Haass & Selkoe have demonstrated that small soluble oligomer intermediates formed
in the aggregation process lead to synaptic dysfunction and that these insoluble Aβ1-42 plaques
can act as “reservoirs of bioactive oligomers” in the etiology of AD (2007). Post-mortem analysis
of AD patient brain tissue has confirmed both morphological hallmarks of the disease, the
extracellular AB protein aggregates, and intracellular hyper-phosphorylated tau protein leading to
cytotoxic insult and ultimately cell death, cognitive decline, and disease progression (Selkoe, 1991,
LaFerna & Green, 2012, Thal & Brak, 2005). Mutations in this tau protein, responsible for
microtubule assembly stability and microtubule binding, result in the protein’s hyperphosphorylation and propensity to form paired helical filaments causing subsequent axonal
damage and neurofibrillary tangle formation (Matsue et al., 1994, Grundke-Iqbal et al., 1986). The
mutations in the aforementioned genetic loci by themselves are not sufficient to cause cognitive
decline associated with AD as studies have shown patients with elevated levels experience normal
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physiologies. Therefore, disease progression is dependent on several other known risk factors
including the apolipoprotein E allele (APOE-e4) in late-onset AD, inflammatory signatures, diet
and exercise, and other environmental factors that affect neuron durability and synaptic coherence
(Stritmatter et al., 1993, Wyss-Coray, 2006, Scarmeas et al., 2009, Butterfield et al., 2002, LaFerla
& Green, 2012). Attention is given specifically to the complex gene-environment interaction of
patients with familial forms of AD by inducing genetic knockouts to pre-existing model organisms
through novel CRISPR/Cas9 systems and assessing relevant behavioral and morphological
changes associated with the given modification. For this study, the triple transgenic mice (3xTg)
contain three mutations associated with familial Alzheimer disease (APP Swedish, MAPT P301L,
and PSEN1 M146V) and display progressive AB deposition as early as three to four months of
age, extracellular deposition in the frontal cortex noticeable by six months becoming more
extensive, and aggregates of altered hyper-phosphorylated tau are detected in the hippocampus
(Oddo et al., 2003, Billings et al., 2005). Corresponding behavioral deficits in hippocampal spatial
memory deficits and long-term potentiation have been determined in 3xTg mice and have
continued to elucidate the age-dependent molecular and physiological manifestations of AD and
other disease states (Billings et al., 2005, Clark et al., 2015, Sterniczuk et al., 2010, Orta-Salazar
et al., 2013).
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Gene Editing by CRISPR/Cas9 Systems
Though the exact nature of the complex interaction of amyloid and tau pathologies in Alzheimer
disease progression is still unresolved, researchers have benefitted greatly from the use of
transgenic mice model organisms to imitate classical disease conditions and inducible genetic
manipulations at sites relevant to human AD pathology through novel CRISPR-Cas9 systems.
Recent literature has cited the development of sequence specific DNA nuclease technologies from
microbial CRISPR (clustered regularly interspaced short palindromic repeat) systems and
programmable Cas9 nucleases that have enhanced the efficiency and accuracy of targeted
modifications to genomic sequences of living cells and model organisms (Ran et al., 2013, Jinek
et al., 2012, Carlson et al., 2012). Studies have shown that targeted mutagenesis using Cas9
nucleases induce double stranded breaks in an organism’s DNA, complementary to the set of guide
RNAs encoding for a given gene of interest, and exploit endogenous cellular repair mechanisms
such as nonhomologous end-joining or homology-directed repair pathways to produce site-specific
knockout at specific genetic loci with minimal toxicity (Katigbak et al., 2018, Cong et al., 2013,
Ran et al., 2013, Thurtle-Schmidt & Lo, 2017). Though various strategies exist to increase the
specificity of genome editing strategies such as zinc-finger nucleases (ZFN) and transcription
activator-like effector nucleases (TALENs) in embryonic cell lines, CRISPR-Cas9 emerges as a
reliable mechanism of eukaryotic homologous recombination and genome-scale KO of
mammalian cell lines (Shalem et al., 2014, San Filippo et al., 2008, Bozas et al., 2009, Chu et al.,
2015). As evident in any field, the cooperation of multiple organizations and individuals with
different skill sets is necessary for robust outcomes. Recently, the development of techniques and
appropriate culture conditions to introduce genetic manipulations to study human genetic diseases
in animal models have expanded the arsenal of researchers and neuroscientists to exploit (Sukoyan
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et al., 2002). The formation of in vivo germ-line competent chimeras containing the genetic
knockout of 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL) against a triple transgenic
background predisposed to AD pathology and implantation into surrogate mothers was able to
produce chimeric offspring (Yamamoto et al., 2013) and relevant behavioral test were conducted.
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Intermittent Metabolic Switching
Under normal physiological conditions, an organism will absorb the nutrients from a given food
source and will store excess energy in the form of glycogen primarily in the liver and skeletal
muscles to maintain healthy blood-glucose levels and supply the tissue with energy in the absence
of oxygen (Berg et al., 2002). As an organism begins to burn off the stored energy with activity
and liver glucose reserves are used up, the brain and body will recognize low circulating glucose
levels and switch the primary energy source of the cells to ketone bodies produced from fatty acids
released by adipose tissue (Mattson et al., 2018, Courchesne-Loyer et al., 2017, Camandola &
Mattson, 2017). The “G-K” switch from glucose to ketone body use as the major energy source of
the cells and subsequent switch back to glucose after food consumption “K-G” has been shown to
greatly improve the phenotypic presentations of various inflammatory pathways, resistance to
neuronal injury and oxidative stress, shown to improve lifespans and age-dependent cognitive
deficits seen in both human and rodent models (Anson et al., 2003, Hatori et al., 2012, Ingram et
al., 1987, Means et al., 1993). As such, the role of metabolic disturbances in disease progression
and lifestyle intervention strategies have seen increasing salience. A recent review article by
Mattson et al. suggests that switching between time-periods of negative energy balance (short
fasts/exercise) and positive energy balance (eating and resting) can optimize brain health, improve
mood, and create the conditions for cellular stress resistance and cell growth/neuroplasticity
pathways in ameliorating neurodegenerative diseases (Longo & Mattson, 2014). Intermittent
metabolic switching can be defined as scenarios in which an individual’s eating and exercise
patterns result in periodic changes in glucose or ketone use as the primary energy source and has
been implicated in providing a range of therapeutic effects including increasing spine density and
LTP capabilities, reduce seizure induced hippocampal neurodegeneration, and even enhance basal
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neurogenesis and neuronal survival (Eckles-Smith et al., 2000, Bruce-Keller et al., 1999, Lee et
al., 2002). The physiological effects of time-restricted feeding (TRF) and alternate-day fasting
(ADF) methods of experimentally inducing IMS in rodent models have been well characterized in
reducing aging-related behavioral deficits seen in 3xTg mice models of AD (Halagappa et al.,
2007, Higami et al., 2006, Huber et al., 2017). Similarly, fasting and exercise have been shown to
upregulate both BDNF and CREB pathways implicated in cellular repair pathways, long-term
memory, insulin-like growth factor (IGF1) signaling and play key roles in mitochondrial
biogenesis and LTP (Hirano et al., 2013, Estrada et al., 2009, Llorens-Martin et al., 2009, Hepple
2009, Marosi et al., 2014). Though the benefits of IMS and caloric restriction/exercise on overall
brain health and disease pathology have been briefly mentioned role of 3-hydroxy-3methylglutaryl-CoA lyase knockout in AD progression has not been previously examined.
Essentially, training regimens of IMS and periods of fasting/exercise followed by periods of
eating/resting can improve the metabolic efficiency and stress tolerance of mitochondria through
SIRT3 pathways, regulate protein synthesis through mechanistic target of rapamycin (mTOR) and
autophagy pathways, and stimulate the release of peripheral signals that mediate neuroplasticity
and behavior (Mattson et al., 2018, Cheng et al., 2016, Palacios et al., 2009, Tang et al., 2002,
Alirezaei et al., 2010, Johnson et al., 2013, Kim et al., 2015).
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3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMGCL)
The HMGCL gene encodes for a protein that belongs to the HMG-CoA lyase family necessary for
ketogenesis and the use of ketone bodies as an alternative energy source by an organisms’ cells
during periods of low blood glucose or fasting. This protein is a mitochondrial enzyme that
catalyzes the final step of leucine degradation in ketone body metabolism and is found on
chromosome 1 of the human genome and chromosome four of the mice genome (The Knockout
Mouse Project). Genetic knockouts at this target loci may produce challenges to cell viability
because of the critical nature of ketone body synthesis and energy expenditure demands of
mitochondrion during periods of fasting, and cell death signatures may be experienced prematurely
by already susceptible hippocampal neurons of the 3xTg mice. Of note, the few HMGCL
mutations that have been investigated in human patients have led to severe metabolic acidosis,
acute metabolic degeneration, and the relevant isoforms of HMGCL transcripts and nature of
mutations lead to potentially lethal outcomes (Grunert et al., 2017, Fu et al., 2010, Mattson et al.,
2018). As such CRISPR-Cas9 mediate genetic knockout of HMGCL in mice models may result in
embryonic lethality and gene expression alterations using RNA guided CRISPR-Cas9 systems
may help potentiate the complex role of ketone body synthesis and use during periods of fasting
(Wang et al., 1998). Regardless of the efficacy of the specific genetic knockout, the use of genome
editing strategies to produce high fidelity mutations at specific loci is significant in order to
elucidate the interaction of specific genotypes with disease and behavioral phenotypes.
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CRISPR/Cas9-mediated 3xTg/HMGCL-/- Chimera Mouse Line from ES Cell
All CRISPR transfection protocol of embryonic cell lines and chimeric mouse generation produced
by Synthego (powered.synthego.com, 2018). Single stem cells are extracted from 3xTg mice
background and electroporation/nucleofection of cell lines with Cas9 and specifically designed
sgRNAs to the HMGCL gene on chromosome four (Catrionia 2013, Fig 1). Multiple sgRNA
transcripts that bind to multiple regions of the HMGCL gene adjacent to a NGG PAM sequence
included in viral transfection to induce DSB at more specific target sites:

5’

CCTGACTCCAAACATGAAAA GG 3’, 5’ TCCTGACTCCAAACATGAAA GG 3’, 5’
GACCACTCTGACGTCTTGAA GG 3’. Cell are selectively cultured for those expressed
mutant germ line DNA and ES cell aggregates are analyzed with qPCR using sequence specific
oligonucleotides to HMGCL labeled with fluorescent EGFP reporter only after hybridization
with its complementary strand (TagMan probes). The real-time PCR analysis of whole brain
tissue of 3xTg/WT ad libitum and 3xTg/HMGCL-/- ad libitum will be conducted and critical
threshold scores are determined. Colocalization of NeuN and HMGCL-EGFP antibody staining
was noted in 3xTg/HMGCL-/- ad libitum relative to NonTg/WT ad libitum. Mouse monoclonal
antibodies received (Chemicon, Catalog number: MAB377) and IHC-Tek antibody diluent
(Cat#IW-1000) used to reduce unspecific staining. Antigen retrieval used IHC-TekTM Epitope
Retrieval Steamer Set (Cat# IW-1102) at 95/100 ºC/room temperature for 20 minutes each. LSAB
method for detection was utilized and nuclei staining was observed.
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Figure 1. Generalized workflow of gene KO at one-cell embryonic stage to produce non-mosaic
gene knockout in all cells followed by surrogate implantation.
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Animals
3xTg mice were ordered from The Jackson Lab; available through the JAX MMRRC Stock#
034830. All mice are housed 5 per cage and kept on 12h light/dark cycles with accessible water
and minimal animal handling. All euthanization techniques and mice testing/handling meet
standards approved by the Institutional Animal Care and Use Committee (IACUC). Intermittent
metabolic switching will be experimentally induced in specific cohorts of 3xTg mice using 24hour periods of restricted feeding with a 40% reduction in caloric intake to determine if the
previously established therapeutic effect of IMS is attenuated in mice with differing genetic
backgrounds HMGCL KO. Time restricted feeding protocols followed previously established
methods and food was deprived every other 24 hours (Halagappa et al., 2007, Anson et al., 2003).
At three months of age, 5 groups of five mice each were assigned to the following dietary regimen:
non-Tg/WT ad libitum, 3xTg/WT ad libitum, 3xTg/WT TRF + CR, 3xTg/HMGCL-/- ad libitum,
and 3xTg/HMGCL-/- TRF + CR. Mice on the CR diet were provided an amount that is 60% of the
amount consumed by the 3xTg/WT ad libitum group. At about 6 months of age, the mice were
subjected to a hippocampal-dependent spatial memory test to better characterize functional
differences in gene knockout and therapeutic efficacy of IMS. CSF fluids were drawn at 6 months
of age and animals were euthanized for whole brain and hippocampal dissection and frozen for
Aβ1-42, p-tau level analysis and Fluoro-Jade B immunostaining.
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Morris Water Maze
Previous studies have shown that both intermittent fasting regimens and caloric restriction
contribute to improved cognitive ability and ultimately reduce risk of Aβ deposition and tau
pathology seen in mouse models of Alzheimer pathology (Halagappa et al., 2007, Mattson et al.,
2015, Patel et al., 2005). The behavioral testing followed previously established protocol. A
circular tank (diameter 1.0 m, height 0.40 m, painted white) was filled with water (22 ± 1°C) and
water made opaque using non-fat milk. Water will be changed after all mice of a given cohort are
tested to prevent detritus buildup. Spatial cues are not provided along the ridge of the tub and mice
given one test run to determine escape latency (s). If mice are unable to find the platform hidden
1 cm below the surface of the water before the maximum 2-minute mark, mice were manually
guide to the platform and allowed to acclimate for 1 minute. On day 1 of acquisition trials, mice
from a given cohort are tested one after another for four cycles as to allow mice to relax between
trials and prevent over-handling. Escape latency or the time it takes each mouse to reach the
submerged platform was recorded using a stopwatch. A 24-hour delay was administered after day
1 of behavioral testing and subsequent preservation or loss of spatial memory is examined.
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ELISA Immunosorbent Assay of Aβ1-42 and p-Tau Levels
Enzyme linked immunosorbent assay (ELISA) kits acquired from ThermoFisher.com for mouse
Aβ1-42 (Catalog number: KMB3441) and phosphorylated tau (p-Tau199, Catalog Number:
KMB7041) level measurements from cerebrospinal fluid (CSF) of 6-month old mice. In an ELISA,
an antigen is immobilized to a solid plate and is complexed with an antibody for a given enzyme.
Elevated insoluble Aβ1-42 levels and phosphorylated tau are well characterized biomarkers of AD
pathology and subsequent shifts in relative concentrations to the NonTg/WT control were
measured (Huber et al., 2017, thermofisher.com). Efficient collection of CSF from cisterna magna
of 6-month old mice followed protocol previously outlined using special stereotaxic guides to hold
the syringe in place to prevent CSF contamination by blood and other fluids (Zarghami et al., 2013,
Rosen et al., 2013). This study could have benefited greatly from repeated measures of minimallyinvasive CSF extractions throughout IMS training initiation at 3-months to see how aging and
cytotoxic biomarkers contribute to cognitive decline.
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Hippocampal Dissection
Hippocampal cell tissue extraction follows standard protocol from previously published studies
(Mathis et al., 2011). The ACSF components 124 NaCl, 2KCl, 1.25 KH2PO4, 2MgSo4, 26
NaHCO3, 10 dextrose (in mM)) were combined with distilled H20 were oxygenated vigorously in
a 2L Erlenmeyer flask. Oxygenated Ca2+-free ACSF poured into separate Erlenmeyer flask and
transferred to ultrafreezer (-80 °C) for 30 minutes to be used during dissection. To produce the
media used for brain slice storage after dissection, 2 mM of CaCl2 was added to remaining 1.25 L
volume of ACSF and oxygenation resumed with 95%O2//5%CO2. Extracted brain tissue
submerged in Ca2+-free ACSF covered with parafilm and prepared for brain slicing from
Vibratome sectioning (Leica VT1000 S). Cerebellum and rostral tips of frontal lobe carefully
dissected out and brain tissue transferred to the sectioning stage of Vibratome filled with ice-cold
Ca2+-free ACSF. Slices collected with wide-mouth paint brush and transferred to small petri dish
containing ice-cold Ca2+-free ACSF. Brain slices transferred to holding chamber to bathe in
oxygenated Ca2+-containing ACSF and chamber temperature increase +1°C every five minutes
to 32°C.
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Cellular Degeneration Identification using Fluoro-Jade B
Fluoro-Jade B has shown to exhibit greater target specificity of neurons undergoing degeneration
with minimal background staining than earlier Fluoro-Jade staining methods (Schmued &
Hopkins, 2000). Fluoro-Jade B positive neuron measurements in this study follow standard
procedures from previously cited literature (Laflamme et al., 2016). Tissue sections mounted on
Superfrost plus slide (Thermo Fisher Scientific, catalog number: 12-550-17 ) and fixed for 20 min
in paraformaldehyde 4%, and 2 minutes in KPBS (Electron Microscopy Science, catalog
number: 19210 ) Dehydrated with 50%-70%-100% Ethanol for 2 minutes each and rehydrated
with 70%-50% Ethanol and KPBS. Incubated in potassium permanganate 0.06% for 5 min at room
temperature, rinsed in water, and incubated in Fluoro-Jade B solution on orbital shaker (Merck
Millipore Corporation, catalog number: AG310 ). Slides kept covered from light and dried under
vacuum at room temperature after three rinses with water. Slide cleared with Xylene three times
at 2 minutes each and slip covered with DPX before drying under hood (Sigma-Aldrich, catalog
number:534056, Electron Microscopy Science, catalog number: 13512). Immunofluorescent of
Fluoro-Jade positive hippocampal cells counted using EVOS FL Auto Imaging System (SKU#
AMAFD1000).
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Confirmation of Gene Knockout
Relative fluorescence of qPCR antibodies for anti-HMGCL loci in 3xTg/HMGCL-/- and
NonTg/WT hippocampal cell homogenates reveal reduced critical threshold value from
NonTg/WT samples. Significant quantities of HMGCL loci binding in NonTg/WT is apparent
nearly twice as quickly than in 3xTg/HMGCL-/- mice samples (Fig 2). Colocalization of NeuN
and HMGCL/EGFP staining reveal HMGCL preservation in physiologically relevant neurons
of the hippocampus but the lack of EGFP-staining suggests genetic knockout compared to the
wild-type (Fig 3).

Figure 2. Diminished critical threshold score from quantitative PCR of 3xTg/WT mice compared
to 3xTg/HMGCL-/- mice (n=1).

Figure 3. Characterization of NeuN and HMGCL-EGFP in a) 3xTg/HMGCL-/- and b)
NonTg/WT
19

Increased Hippocampal-Dependent Spatial Memory Deficits seen in 3xTg HMGCL-/- mice
Mean escape latency measurements trends suggest similar cognitive phenotypes of NonTg/WT
and 3xTg/WT mice on the TRF + CR regimen (Fig. 4). The phenotypic presentation of 3xTg/WT
ad libitum mice in spatial memory behavioral tests have been well characterized in recent
Alzheimer disease mice models, demonstrate delayed learning speed and altered retention of
spatial memory, and serves as the control to compare behavioral data (Huber et al., 2017,
Sterniczuk et al., 2010, Gimenez-Llort et al., 2013, Clinton et al, 2007). Latency reduction of 3xTg
and memory preservation is evident between 3xTg/WT ad libitum and 3xTg/WT TRF+CR cohorts
as evidenced by consistent latency times following the 24-hour break in the IMS induced mice.
Interestingly, the escape latencies of both HMGCL KO mice regardless of training regimen
experience marked differences in mean latency scores and the IMS training regimen was not
sufficient to improve cognitive deficit attenuation seen in 3xTg/WT TRF+CR compared to
3xTg/WT ad libitum trials. The 3xTg/HMGCL-/- mice exhibit significantly longer escape latency
times with the mice swimming close to the maximum allotted swim time with each trial, and
significant latency reductions were not observed between trials such as in the 3xTg/WT TRF+CR
mice (Fig 4.) All groups see a similar upward trend toward the end of their acquisition trials likely
due to over-handling.
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24 HOUR
DELAY

Figure 4. Summary of mean escape latency of hippocampal-dependent MWM cognitive tests
(n=5). NonTg/WT = dashed square; 3xTg/WT TRF + CR = blue circle; 3xTg/WT ad libitum =
blue triangle; 3xTg/HMGCL-/- TRF + CR = grey diamond; 3xTg/HMGCL-/- ad libitum = grey
square
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Elevated Aβ1-42 and p-Tau199 from CSF
ELISA Immunosorbent Assay analysis of insoluble Aβ1-42 from the five cohorts reveal
significantly elevated concentrations in 3xTg/WT ad libitum compared to NonTg/WT and
3xTg/WT TRF + CR (Fig 5). Interestingly, though 3xTg/WT TRF+CR show slightly elevated
concentrations of Aβ1-42 protein, statistical significance is not determined. Mice in the
3xTg/HMGCL-/- TRF + CR cohort show ~35% increase in Aβ concentration compared to
3xTg/WT mice experiencing the same IMS regimen whereas 3xTg/HMGCL -/- ad libitum
experience a 250% increase in Aβ accumulation. Analysis of phosphorylation of tau protein at
Ser199 of the wild-type and chimeric mice reveal similar concentrations between NonTg/WT ad
libitum and 3xTg/WT TRF+CR. A nearly 50% increase in p-tau concentration is noticed in
3xTg/WT ad libitum mice relative to controls for transgene and IMS regimen. Both
3xTg/HMGCL-/- exhibit nearly 200% increases in phosphorylated tau concentrations and
correlate with the worst phenotypic presentations in Morris Water Maze.

Figure 5. Relative Aβ1-42 and p-tau levels normalized to NonTg/WT mice and significant
associations between HMGCL KO and experimental conditions are identified (n=5).
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Fluoro-Jade B Positive Staining of Hippocampal Slices
Hippocampal neurons exhibiting positive Fluoro-Jade B staining were elevated to noticeable levels
in 3xTg KO mice and IMS training regimen was insufficient to ameliorate cell degeneration
processes (Fig 6.) The 3xTg/WT ad libitum mice experience one order of magnitude larger in cell
death markers relative to 3xTg/WT TRF+CR and NonTg/WT cohorts. However, insignificant
differences were determined between 3xTg/WT ad libitum and 3xTg/HMGCL-/- TRF+CR mice.
The elevated counts of Fluoro-Jade B positive hippocampal neurons in 3xTg/HMGCL-/- ad
libitum mice were expected but a significant difference existed with the 3xTg/HMGCL-/TRF+CR.

Figure 6. Fluoro-Jade B fluorescent neurons in the hippocampus seen noticeably in HMGCL KO
mice and IMS regimen could not recover memory deficits or attenuate Aβ and p-tau levels (n=5).
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Discussion
An increasingly sedentary and overindulgent lifestyle of modern Western societies have shown
to contribute to complex pathologies of various metabolic and neurodegenerative conditions.
The therapeutic potential of IMS and everyday lifestyle management shifts have been attributed
to a variety of neuroprotective, synaptic plasticity, and attenuating cognitive decline in both
human and AD animal models. Current research continues to elucidate the role of diet and
exercise in decelerating disease progression and providing neuroprotective pathways against
pathogenesis. This paper has addressed the three specific hypotheses originally posited by
successful genetic and visual confirmation of targeted knockout of chimeric mouse strains
predisposed for AD pathology, demonstration of the hippocampal-dependent spatial memory
deficit mitigation of intermittent metabolic switching regimens to 3xTg mice, and analysis of
the classical hallmarks of Aβ1-42, p-tau and cell degeneration biomarkers. As expected,
NonTg/WT and 3xTg/WT TRF+CR mice exhibited similar cognitive abilities in MWM and
relative concentrations of the enzymes and proteins associated with AD pathology leading to
cellular death (Fig 4). IMS has been shown to enhance cell-stress resistance and neuroplasticity,
the relatively low levels of Fluoro-Jade B staining of 3xTg/WT TRF+CR a make sense as more
neurons are resilient to the degrading nature of Aβ oligomers and phosphorylated tau. Initially,
it was expected that mice receiving TRF+CR training regimen would experience overall
improvements in behavioral abilities and phenotypic presentations but the 3xTg/HMGCL-/TRF+CR performed relatively poorly in all aspects. Interestingly, in both HMGCL KO cohorts,
marked elevations in Aβ1-42 and p-tau proteins were recognized. The necessary role of HMGCL
protein in proper mitochondrial function during the fasting period and subsequent gene editing of
this loci may contribute to the increase in cell death markers seen in HMGCL KO cohorts relative
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to 3xTg/WT mice. Mice following the IMS diet in the 3xTg/HMGCL-/- group showed decreased
relative Aβ1-42, pTau, and Fluoro-Jade B positive staining relative to ad libitum groups. The
ability of TRF+CR to prepare neuronal populations for stressful environments and subsequent
neuronal degeneration from aberrant amyloid and tau pathologies is evidenced by the decreased
Fluoro-Jade staining seen in 3xTg/HMGCL-/- TRF + CR compared to 3xTg/HMGCL-/- ad
libitum. The creation of chimeric mouse strains encoding for HMGCL enzyme knockout against
a genetic background predisposed for AD progression highlights the complex interaction of the
gene and environment on phenotypic presentations of a disease and a patient’s response to a given
therapeutic. The application of high fidelity genome editing and growing understanding of
embryonic cell lines and genomic analysis continue to improve the arsenal of researchers to
reliably translate genomic data into personalized treatments. Manipulating CRISPR/Cas9 systems
for targeted gene expression modifications instead of permanent genetic knockout is emerging at
the forefront of gene therapies and mouse models of disease pathologies. With a growing
understanding of functional genomics and endogenous gene expression modifications, researchers
may refine the CRISPR/Cas9 systems to non-invasively, non-permanently alter protein expression
and functional/phenotypic presentations can be measured. Differing training regimens such as
longer food restriction periods or exercise-coupled IMS may contribute to different degrees of
cognitive attenuation and the exact nature of IMS regimens could be further developed. Ultimately,
an individual’s genetic makeup may determine the propensity for aberrant signaling and cellular
dysfunction but environmental cues and lifestyle characteristics play a huge role in the pathologies
of neurodegenerative diseases. Currently, randomized, double blind clinical trials prescribing
individualized training regimens for older patients at risk for developing dementia-like disorders
is underway and clinical applications of daily lifestyle management may be seen as early as 2018.
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